Reactor design and selection for effective continuous manufacturing of pharmaceuticals

Area of Science:

• Chemical Engineering
• Pharmaceutical Manufacturing

Background:

• Traditional pharmaceutical batch processes are inefficient, leading to long lead times and potential drug shortages.
• Continuous manufacturing offers advantages like cost reduction, enhanced quality assurance, and shortened production cycles.

Purpose of the Study:

• To summarize theories and models for selecting and designing reactors for continuous pharmaceutical reactions.
• To provide examples of plug flow reactors (PFRs) and continuous-stirred tank reactors (CSTRs)-in-series applications.
• To emphasize the integration of Process Analytical Technologies (PATs) in reactor design.

Main Methods:

• Review of relevant theories and models for continuous reaction engineering.
• Analysis of PFR and CSTR-in-series configurations in pharmaceutical contexts.
• Discussion on integrating PATs for real-time reaction monitoring.

Main Results:

• Selection and design of reactors are critical for optimizing selectivity and yield in continuous processes.
• PFRs and CSTRs-in-series are viable reactor configurations for pharmaceutical applications.
• Consideration of factors like density changes, fouling, and scale-up is essential for successful implementation.

Conclusions:

• Continuous manufacturing presents a significant improvement over traditional batch processes in the pharmaceutical industry.
• Effective reactor selection and design, incorporating PATs, are key to realizing the benefits of continuous pharmaceutical production.
• Addressing practical challenges like clogging and scale-up ensures robust and efficient continuous manufacturing.